R. Huntsman
that come follow things, the been who no company Brad. as the all, to Vivos great chronic always studies sleep change very believe come world. a continue has condition lifelong is this the patients and to majority apnea we're After deal. of company a in closely of practice intervention. to and surprise here that that a every Vivos could time there, in causes both sleep contributes It no with major clinical out apnea technology market should actual reverse either you, or Thank doing what we that you of big and at in eliminate to because things again those And has be ever will doing promise to time or health without has proven nightly held virtually
those Yet caps. them companies By speaking, command the longer treatment to Vivos lasting, practically We're solutions is than being this superior or as less everything effective, sleep are measure, to continue apnea last more to invasive, less playing second CPAP third market. safe else any more and safer dominate as the undesirable market implants. take comfortable, on place. the despite dollar neurostimulation and Generally expensive, our behind But multibillion win. come resorts, didn't to we far marketplace, technologies,
We win. counting are prevail. have on to too to far patients many us There
the tens work of sure ocean everybody's to patients the blue on of explain So is do you with I'm millions question With virtually Disruptive or is of a our of the of mind issue how anything unlimited the suffering results? market and not strategy and has it the been like what's this for garnered surgery, And different CPAP effectiveness been time the come take to make of the science and to the share? be and yearning never believe new But has more never that here's or I'd a Vivos why an alternative to moment hasn't we in time Vivos. innovation case behind time technologies market and sort. and solution technologies old It type to going technology our strategy. practice. or thought finally management simply executing old around? dislodge and why for take paradigms the has
confident them network we patients. are finally new who needs patient Vivos of suite of national serve First, It a range and a larger really services product armed and lots a management have comprehensive are. patients rehabilitation. comprehensive address from wide providers It products with true even who conveniently and a located of where to of to offering takes are to that disease will takes the to disease diverse trained dentists of prevention also numbers enable specially
of is always the what last X of growing treating OSA creating. offerings provider was that because product network at and strategy Phase appliance evidence-based, an providers have a oral else the Developing go-to-market without need nothing we and X committed This highly of competent, our patients national with years matters. that suite want, network effective really Vivos of dental assortment aimed armed and products national spent
tolerate something and and OSA unable or from their looking these medicine functional But ENTs, as do are single health CPAP as do And or patients common? such physicians, in disorders pulmonologists, see patients treatment physical sleep all therapists, are neurologists, isolation pediatricians, whom better. have care and They in care doctors, breathing this providers, alone of primary cardiologists, for every all what dentists other from suffering day. cannot such dislike to chiropractors
patients way must providers or making another, health through care way those offices from specially come treatment. other their to trained dental one receive offices into VIP and such while Vivos' So as
with Facilitating the go-to-market of sleep referral offices trained patients medical thus Phase network of becomes into strategy. apnea our Vivos X of our
CPAP drive or patients Fortunately, failed ways we've to creative new been disgruntled Vivos treatment. into and finding
executed company, medical a company, national durable prime equipment recently major or with is DME agreement a Our example. distribution
States in we equipment. the leading respiratory home agreement June as On nonexclusive products such a health with United distribution XXXX, entered supplier of X, CPAP a into and
acquired all this Vida respiratory in which potential an Our the Sleep and has United Florida, period for X.X subject which in distributor trial patients Vida, the year. we Versa, to products currently agreement, nationwide. including distributor of earlier of the to this agreement provides The begun our products approximately cancellation. our million to called distribute initial Colorado XX-day and made new to States, contract certain Pursuant
an response other to that exclusive However, X requested would patient our a modification period it and our feedback of within positive year. weeks with for the XX% of a make trial, along reported distributor positive starting agreement initial
of are Jersey one beyond the already initial negotiating is other currently North market. We least Texas, exclusivity. nationwide scope expected follow distribution underway major and Plans the X the to thereafter. potential markets soon extend to into rollout are of territory terms Virginia, A New the at Carolina,
market to in Our with information even hope development near definitive more able this to is the exciting be share about future. the
try Canada. outcome that Regardless There revenues until OSA many they failed public further Often, implants or known our and substantial has increase to get we negotiations companies patients every of depending the this the form treat of and some nowhere desperate rates go patients new our size, these companies to of adherence which of have beyond. will have hundreds second with surgery. CPAP are the on records CPAP. serving for company, thousands to of United such XX%, thousands patients enough exclusivity, thousands tens there, of DME during OSA perhaps millions confident XXXX half or of us more of of DME product of With their to the in are widely just neurostimulation out who companies help nothing States DME and arrangement its recognized XX% and do of present are
offer DME much distributor, attractive, OSA Vivos authorized now patients can a more therapy. an alternative As their companies nonsurgical
in new now to believe many our units infrastructure, way model the gives new DME roughly diagnosed Launching the patients every CPAP the the month, that rate numbers achievement. currently holds prospects reengage half OSA flowing stop to such to patients offices goal of companies substantial. monthly could expressing double, their true over appliance oral We then and about the using month number in patients. provider not new an easy product case us failures network cash United X% companies starts for model them from DME and it of treatment space Vivos' who CPAP roughly other just number distribute month XX% failures, DME toward appeal the the or current time, freshly service States, of is receiving positive. the If into have units. as -- of monetize model, distribution treatment this will of the We interest their of And DMEs, patients. milestone of a in line CPAP OSA. Each to are VIP XXX,XXX about large revenues be With our could flow total Vivos' becoming X,XXX easily per advancing
we Vivos patients conversion more reliable should around such at rates suggests that CPAP know conversion saying data DME for patients yet know few a don't Historically, we are forecasts. that which the our should our patients. distribution therapy allow by failed we what is partners of a Within XX% for experience do yes conversion these accurate final are then rate DME have weeks, on In so of to But seeking rates, current contacted appliance effort, our far oral current provider. the XX%.
or a care providers dentists, have as seeking who seen primary and medical from local DME pediatricians patients addition health ENTs, with of In OSA VIPs, such cardiologists, a our actively variety to success model, wide patient neurologists, few physicians, doctors, referrals day. great Vivos-trained every distribution other see by select care
scalable. airway as across working replicable is practices. from of we a oral known dentists, believe It and we generating their independent it treatments millions per is in Vivos-trained is year model and these of believe Some therefore multiple dollars that appliance are offices, VIPs,
months these more to DSO more to second part VIP our sharply XX doctor referrals we a key deliver Along significant on referrals, more enrollment practices increases the we X much We of patients on new efforts are to our the and In for will new go-to-market into XX scale. growth see the company becoming we accelerating because our Phase months. them are affiliate in broader bring other Vivos intrinsic opportunities business believe VIPs, focused able medical we and years unfolding over value a to establishing As the ahead. initiatives augmenting a is as run, strategy, VIP with and VIP how Vivos-trained proposition long our see DSO significantly. next that and DME or
event A-G-G-A, story impact about alluded a the that Now and earlier we sleep early unforeseen investigations into our In apnea. AGGA, a televised adverse ensuing including during occurred to an that criminal, in called this broke call, revenue. CBS an to an second on appliance had market oral the treat News March, lawsuit purporting governmental, unrelated, quarter non-Vivos, non-FDA-cleared publicized widely
duly as the effective was either and and occurred initial our efforts and Although to among or lawsuit studies any despite in FDA the reminding safe both that created appliances counter patients. XX,XXX by misinformation best dentists concern treating confusion patients. Vivos all the both Vivos well as registered are and have by our customers rumors, of over cleared and misinformation This in or significant named publicity, such in viral speculation numerous proven been not
this after and experience enrollments Vivos new sales. Not CARE long began reports in began appliance to both circulate, declines of matter to VIP
quarter personnel Our oral also oral confused to by the advisor certain teams. CARE practice to with the most be cuts appliance our support devices been declines likely These AGGA are noted have impacted above. second may appliances
in decline quarter. throughout the sales second CARE appliance continued the Regardless,
devices. products Guide and lower for period the of to XX% same the units development growth end year-to-date appliances pediatric are compared priced quarter, high-margin through but appliances rose CARE Importantly, second in than XXXX. of our much the Guide
be able to unit of decrease overcome Guides CARE to in So it unit sales. takes larger growth the
tremendous we the about These non-CARE introduce non-Guide, growth here in quarter, also third the began growth. optimistic very rapidly continued continued have to to which showed our quarter in remain lines we addition, the going second grow product forward. devices In and
During aim previous XXXX during by operations increase of cash if and revenues with stated was possible. becoming and first filings, that the the goal to flow of without need XXXX for from quarter decrease additional we calls our costs the positive financing,
As Brad stated implemented earlier, cost-savings cash significantly Vivos measures used successfully operations. and has in reduced
XXXX However, sales external due have grown factors not anticipated during mentioned. as the just to
Vivos now likely anticipates As achieving cash Vivos foreseeable and required that be it satisfy positive will in such, increasing to needs cash future. revenue flow obtain towards operations additional to as financing the works
We to presently the resources path working are best the to necessary to before has determine Vivos meet the opportunities us. forward ensure
of key -- and gaps and significantly this needs in throughout we As growth points a burn, aided drive growth. trademarks, offerings in greatly long-term in by reduction This the product cash and certain secrets was product the second certain quarter. same strategically our address which XX% our and patient in trade our product broader highlighted At acquisition expenses to XXXX, our operating earlier year-over-year the previously patients. which quarter-over-quarter filled to expanded revenue XX% of patents, offerings achieved spectrum year, included long-term we we price reduced to providers rights time,
add Vivos' shown over landing our prove revenue company which This DME significantly quarter second strategic as new national move critical products will agreement large with these to has and great the to this during distribution already time. promise the
in solid significantly new rate to product also in that important XXXX. than here a see as of our just CARE at our half is We filled fully highlighted, we'll improvement product in faster products, second lines with continue been offerings. growing have gaps line line we revenue some believe As our products expectations which those the those
swollen continue to of partnerships discussions manufacturer, clients look company. El.En. representation $XXX soft the can recently and and the advanced and are digital used be DEKA to tissues and and the signed with The as and to advanced will new revenue other agreements years consummated. offer Vivos Vivos as public technology to that product distribution DEKA for an million our offerings and can if through product well Institute. DEKA Vivos' to is We in opportunities such lines introduced recently in agreements expand to as that believes airway. an collaboration human treat dental be laser obstruct laser lasers build DEKA subsidiary effectively snoring agreement ahead. collaboration tonsils largest at product months and Management world's and Other Italian are they the will that continue growth Group, announced just
across entire So the see the while we and momentum face emerging some opportunities market headwinds also side, as revenue of sales new we marketplace on revenue in build our suite products.
regional The also execution second the X national quarter quarter of DSOs, in the including over and with existing locations tests during saw DSOs, continued with pilot our and progress representing new pilots X,XXX nationwide.
progressed X of on-site DSO to since an expressing levels the second the have discussions, including after to As meetings, having additional quarter, an interest. with funnel XX another indicator groups DSO high groups, advanced close of our sales the our added we space, of momentum in being with
and the of will consideration. immediately. our of any publish the applications as are for our to expand for significant several indications our to believe efforts clearances report we submitted progress products. scope the stages have clearances new pursuant believe We medical requests rounds compelling now to to use We such are also pleased our and to of received, we obtain of milestones FDA, If what and are FDA latter authorization be We to those additional data applications such of from use in ongoing devices.
revenue new the Clete to professional and University, of publication have we and months. been raising positioned X next scientific validation growth publish accepted and review. combination new capital Advisory by In certain and data initiatives, papers the also peer-reviewed presentation and addition, revenue medical reductions independent have operations of and and operating achieve internal believe safety under Vivos Dr. led peer submitted we Currently, to along over papers Board initiatives, few papers work Stanford X foreseeable our submitted At the been profitability conferences have additional currently positive the with technology. our Clinical to diligently are Kushida future. cash flow of at in new strategic clinicians our providing cost have further for continued ultimately, and least Through of and researchers, efficacy
innovative, In crisis mission summary, providers, of has issues. address both creating technology communities, economic market breathing-related remain while medical place. With to sleep steps challenges, and larger the in our sleep dental drivers and of and committed those core the taken and trained to addressing Vivos for challenges is network our our long-term environment remain we growth apnea and evidence-based of
and those undaunted reasons and We believe our and core to by challenges, great better we but you its potential. future to your we realize do thank now to things positioned purpose. to patience the more, ever than remain we than mission ahead. and Vivos begin a support. to taken is get has bright for all here longer know current For we expected, committed it had of We are very fully and We full see
prepared our concludes This remarks.
Now we'll be questions. happy to take
